Document is current
Any future updates will be listed below
-
Authors
Shenvi, Christina https://orcid.org/0000-0003-2944-8581
Fuller, Jessica https://orcid.org/0009-0008-0346-320X
Alexander, Seth McKenzie https://orcid.org/0000-0002-2706-2696
Scherrer, Kristen Hymel https://orcid.org/0000-0002-4023-1706
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 27 December 2025
First Online: 7 January 2026
Declarations
:
: The authors have no disclosures or competing interests relevant to this work. Author CS has the following disclosures for the past 2 years: speaker for AstraZeneca, advisory board for Noven Pharmaceuticals.
: During the preparation of this work the authors used Chat GPT4.0 in order to proofread and provide writing feedback. After using this tool/service, the authors reviewed and edited the content thoroughly and take full responsibility for the content of the publication.
: The study was reviewed by the Institutional Review Board (#22-1797) and deemed exempt.
